R. Hector MacKay-Dunn - 11 May 2021 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ R. Hector MacKay-Dunn, Q.C.
Issuer symbol
AUPH
Transactions as of
11 May 2021
Net transactions value
+$50,529
Form type
4
Filing time
13 May 2021, 16:17:55 UTC
Next filing
16 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Purchase $5,585 +500 +33% $11.17 2,000 11 May 2021 Direct
transaction AUPH Common Stock Purchase $11,140 +1,000 +50% $11.14 3,000 11 May 2021 Direct
transaction AUPH Common Stock Purchase $15,764 +1,400 +47% $11.26 4,400 12 May 2021 Direct
transaction AUPH Common Stock Purchase $18,040 +1,600 +36% $11.28 6,000 12 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.